ArticleScientific reports2025
Impact of nitrosative stress and endothelial damage on angioinvasive papillary thyroid cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Integrated Cytokine, Metabolic, and Proliferative Profiling Reveals Divergent Metabolic and Proliferative Responses in Papillary Thyroid Cancer Cells.International journal of molecular sciences · 2026Article
- Modulation of oxidative stress and metabolic burden in papillary thyroid cancer by SGLT2 and broad DPP inhibition.Frontiers in molecular biosciences · 2026Article
- Postoperative serum oxidative stress measures in women with papillary thyroid cancer.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Papillary thyroid cancer (PTC) typically has a favorable prognosis. However, in some cases, the presence of angioinvasion can result in local invasion, recurrence, and distant metastasis, leading to poorer outcomes. Identifying disrupted pathways associated with angioinvasion could lead to the discovery of novel angioinvasive markers in PTC, which, in turn, may suggest more aggressive clinical management strategies, as radioiodine therapy (RAI). This study aims to identify potential markers associated with angioinvasive PTC, with a particular focus on nitrosative stress and endothelial damage. For the purpose of this study, 45 patients with angioinvasive PTC (study group) and 45 patients without angioinvasion and characterized by a very low risk of cancer progression (reference group) were enrolled. We assessed the levels of total antioxidant capacity (TAC), 3-nitrotyrosine (3-NT), placental growth factor (PLGF), integrin subunit alpha V (ITGAV), and integrin subunit alpha V beta 3 (ITGαVβ3) as potential markers for angioinvasion. Our results revealed significant alterations in the concentration patterns of these markers, suggesting their potential utility as screening tools for angioinvasion and as prognostic indicators in PTC patients. Specifically, elevated levels of 3-NT, PLGF, ITGAV, and ITGαVβ3 were observed, while TAC levels were decreased in the study group compared to the reference group (all, p < 0.05). Logistic regression analysis confirmed a significant association of TAC, 3-NT, and PLGF with the occurrence of angioinvasion. PLGF demonstrated an area under the curve (AUC) of 0.82, indicating its clinical significance. However, to enhance screening utility for clinical management, a panel consisting of 3-NT, TAC, and PLGF assessments was created, demonstrating the highest potential utility as an angioinvasion screening tool (3-NT + TAC + PLGF AUC = 0.95).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.